INS and gestational diabetes: A cohort of women with GDM documented that the use of insulin as a treatment for GDM—which is an indicator of the most severe form of the disease—compared to treating GDM with diet alone was associated with a much higher risk (OR: 3.11; 95% CI 1.37, 7.05; p = 0.0076) of delayed secretory activation [26].